Echo Street Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Echo Street Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $79,676 - $104,921	-2,154 Reduced 19.0%	9,183 $368,000
Q4 2022 Feb 13, 2023	SELL	$33.72 - $46.33 $147,390 - $202,508	-4,371 Reduced 27.83%	11,337 $525,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $627,691 - $1.04 Million	15,708 New	15,708 $650,000
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $147,430 - $274,902	-3,219 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $200,221 - $271,683	3,219 New	3,219 $234,000
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $341,572 - $407,143	-4,634 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $527,752 - $693,555	-6,773 Reduced 59.38%	4,634 $418,000
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $476,622 - $598,220	5,170 Added 82.89%	11,407 $1.09 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $666,735 - $1.05 Million	6,237 New	6,237 $710,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.